+ Discretionary annual bonus
Bain Capital is a private investment firm that manages multiple asset classes including private equity, venture capital, public equity, credit, and real estate. It works by making long-term investments in companies across a wide range of industries and geographies, and then actively partnering with the management teams of portfolio companies to drive growth and improve operations over time. The firm uses a long-term investment horizon and an active-ownership approach to build value for its investors. What sets Bain Capital apart is its multi-asset scale and global presence, combined with hands-on collaboration with portfolio companies and a strong emphasis on social responsibility through charitable initiatives. The goal is to deliver sustained, long-term value for investors and partners while contributing to communities through its charitable programs.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
$17.3B
Headquarters
Boston, Massachusetts
Founded
1984
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Professional Development Budget
Conference Attendance Budget
Bain Capital, LP agreed to acquire Solitude Lake Management, LLC from Rentokil Initial plc for $230 million. Published on 09/22/2026 at 11:49 am EDT S&P Capital IQ Bain Capital, LP agreed to acquire Solitude Lake Management, LLC from Rentokil Initial plc (LSE:RTO) for $230 million on September 22, 2026. A cash consideration of $230 million will be paid by Bain Capital, LP. As part of consideration, $230 million is paid towards common equity of Solitude Lake Management, LLC. Total estimated net cash proceeds after tax are expected to be around $180m. Post-acquisition Solitude Lake Management, LLC will operate as an independent company. For the period ending December 31, 2025, Solitude Lake Management, LLC reported total revenue of $112 million and an adjusted operating profit of $16 million. The transaction is valued at 2.05x revenue and 14.38x adjusted operating profit. The transaction is subject to Hart-Scott-Rodino clearance and is expected to be completed by early in the fourth quarter of 2026. Rentokil Initial plc intends to use the net proceeds from the sale to reduce leverage and support its capital allocation priorities. Goldman Sachs & Co. LLC acted as the sole financial advisor to Rentokil Initial plc on the transaction. (C) S&P Capital IQ - 2026
Rentokil to sell SOLitude and Vertex to Bain Capital for $230m. 319.60p. 13:34 22/09/26. Rentokil Initial said on Tuesday that it has agreed to sell SOLitude Lake Management and its Vertex Aquatic Solutions division to Bain Capital for $230m. 10,754.49. 5,863.93. 5,799.73. 10,714.81. Total estimated net cash proceeds after tax are expected to be around $180m. Rentokil noted that in FY 2025, SOLitude - which has become the leading lake and pond management company in the US - generated revenue of $112m and adjusted operating profit of $16m. The company said the deal further reduces leverage within its target range, supporting Rentokil's capital allocation priorities to invest in organic growth and bolt-on M&A, pay a progressive dividend and then return surplus capital to shareholders. Chief executive Mike Duffy said: "This transaction supports its strategy of building a platform for sustainable profitable growth through greater simplification of the organisation and specifically prioritising its highest opportunity markets and categories. "The disposal further strengthens our balance sheet as we look to accelerate growth and improve margins and free cash flow and deliver on the clear opportunity for shareholder value creation."
PizzaExpress explores sale at valuation of up to £500m - report. The restaurant chain is working with Rothschild after receiving interest from industry bidders and private equity companies. UK-based restaurant chain PizzaExpress is preparing for a potential sale that could assign the business a valuation of as much as £500m ($669m), according to a Financial Times (FT) report, citing sources familiar with the matter. Backed by investors such as Cyrus Capital Partners and Bain Capital's special situations division, PizzaExpress appointed advisers at Rothschild following acquisition approaches from both trade buyers and private equity companies. The aforementioned sources added that discussions are currently in their early stages with no guarantee of a completed transaction. Founded in London's Soho in 1965, PizzaExpress has grown its footprint to more than 360 locations across the UK and Ireland, alongside franchise operations across a dozen international markets. The company recently moved into the fried chicken category by agreeing to add US brand Houston Hot Chicken to its portfolio. It also introduced a dedicated takeaway menu featuring chicken wings alongside macaroni and cheese in March. For the 2025 financial year, PizzaExpress generated flat revenue of £440m while its adjusted earnings before interest, tax, depreciation, and amortisation (EBITDA) rose 6.3% to £53m. During the first quarter of 2026, the company reported sales of £112m, representing a 3.7% increase compared with the corresponding quarter of the prior year. The group is controlled by creditors who took charge after the disruption of the Covid-19 pandemic prompted a comprehensive restructuring that included closing dozens of dining locations. Shareholders contributed £20m of fresh equity to the business in April 2025 as part of a broader £55m refinancing package. Prior to the takeover by Bain and other lenders in 2020, PizzaExpress was owned by Chinese private equity group Hony Capital, which acquired the chain in a debt-funded £900m transaction in 2014. Give your business an edge with its leading industry insights.
Inside Surgery Partners' $797M bet on an ASC future. By: Francesca Mathewes Brentwood, Tenn.-based Surgery Partners completed the $797 million sale of its ownership interests in Idaho Falls Community Hospital and Mountain View Hospital to Salt Lake City-based Intermountain Health on Sept. 17, pushing the company further from the inpatient hospital business and deeper into ambulatory surgery. The deal, which values the two Idaho Falls, Idaho, facilities at about $1.15 billion combined, gives Intermountain majority ownership of the 126-bed system while preserving its local brands, management and the existing physician ownership stake in Mountain View Hospital. The combined operations include more than 150 physicians and nine surgical specialties, along with oncology, emergency, ICU and neonatology services. Surgery Partners will use most of the $587 million in net proceeds to pay down debt, a move the company said will improve its leverage by 30 basis points. For Surgery Partners, the sale is about more than one transaction. It's about where the company has decided its future lies. "With the completion of this important transaction, Surgery Partners enters a new chapter better positioned for long-term growth as a pure-play short-stay surgical provider," CEO Eric Evans said in a Sept. 17 news release. The Idaho Falls sale is the most significant step yet in a broader narrowing of Surgery Partners' hospital footprint. Alongside the transaction, the company lowered its 2026 revenue guidance to a pro forma range of $2.6 billion to $2.67 billion, excluding the divested facilities, and outlined plans to shed neonatology, obstetrics, pediatrics and pharmacy services elsewhere in its portfolio while reducing its Medicaid payer mix by about 50%. In a March 10 open letter to stockholders, New York-based Ortelius Advisors, led by managing member Peter DeSorcy, called on Surgery Partners to monetize all of its surgical hospitals to generate what it argued could be billions of dollars in asset sales, and to use the proceeds to repurchase stock and pay down debt. The firm also pushed for a board refresh and new management, pointing to a stock that had fallen 67% over five years and underperformed its benchmark by 108 percentage points. The Idaho Falls sale fits a pattern Surgery Partners has followed for several years: paring capital-intensive hospital assets while funneling investment into ambulatory surgery centers, particularly in orthopedics and cardiology. The company opened eight de novo ASCs in 2024 and two more in 2025, and it now has nine facilities under construction and more than a dozen in additional development. It also walked away from a $3.2 billion buyout offer from Bain Capital last year, with Chairman Brent Turner citing confidence in the company's joint-venture model, and it has kept building outpatient partnerships, including a joint venture with Dallas-based Baylor Scott & White Health and this year's acquisition of Preferred Vascular Group, a network of office-based labs that perform dialysis access procedures. Surgery Partners did not name additional hospitals under review for sale. But with the Idaho Falls transaction closed, Mr. Evans' description of the company as a "pure-play short-stay surgical provider" suggests the hospital side of its business may keep shrinking. At the Becker's 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now. Wednesday, September 23 11:00 AM - 12:00 PM CDT Presenter: Jerrilyn Ivey, CCS-P, CPCD, CPMA, MHA, MBA, NextGen Healthcare Next up in ASC transactions & valuation issues. * Elevance hit with another lawsuit over out-of-network penalty policy Elevance Health's out-of-network penalty policy has been met with significant resistance - and another lawsuit filed Sept. 17 is adding... By: Elizabeth Casolo * Maryland nurse pleads guilty in $14M DC Medicaid fraud A Bowie, Md., nurse has pleaded guilty to conspiracy to commit healthcare fraud for her role in a $14 million... By: Patsy Newitt * 3 physician practice closures in 10 days Becker's has reported on three physician practices since Sept. 9, spanning three states and two specialties, from orthopedics to cardiology... By: Patsy Newitt
HST Pathways (“HST”) and Casetabs, two leading providers of innovative, cloud-based software for ambulatory surgery centers (“ASCs”) across the U.S., today a...